Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,256.80
-7.60 (-0.34%)
Apr 29, 2026, 3:29 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 931.67 billion as of April 29, 2026. Its market cap has decreased by -5.26% in one year.
Market Cap
931.67B
Enterprise Value
982.80B
Revenue
139.14B
Ranking
n/a
PE Ratio
52.23
Stock Price
2,256.80
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 931.67B, an increase of 63.52%. That is a compound annual growth rate of 17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 931.67B | 2.75% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 945.51B |
| Cipla | 1,064.01B |
| Aurobindo Pharma | 822.82B |
| Glenmark Pharmaceuticals | 656.15B |
| Alkem Laboratories | 638.96B |
| Laurus Labs | 606.56B |
| Divi's Laboratories | 1,719.44B |
| Ipca Laboratories | 391.03B |